This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Villeneuve, J. Articles by Vallières, L. Search for Related Content PubMed PubMed Citation Articles by Villeneuve, J. Articles by Vallières, L.

Tumor Necrosis Factor Reduces Brain Tumor Growth by Enhancing Macrophage Recruitment and Microcyst Formation

Department of Oncology and Molecular Endocrinology, Laval University Hospital Research Center, Québec City, Québec, Canada

Requests for reprints: Luc Vallières, Department of Oncology and Molecular Endocrinology, Laval University Hospital Research Center, 2705 Laurier Boulevard, T3-67, Québec City, Québec, Canada G1V 4G2. Phone: 418-654-2296; Fax: 418-654-2761; E-mail: Luc.Vallieres{at}crchul.ulaval.ca.

Recent findings implicate macrophages and some of their secreted products, especially tumor necrosis factor (TNF), as tumor promoters. Inhibitors of these inflammatory components are currently regarded as potential therapeutic tools to block tumor progression. Here, we show that infiltrating macrophages represented a significant population of nonneoplastic cells within malignant gliomas, in which they were the exclusive producers of TNF. Contrary to the reported pro-oncogenic effects of TNF in other types of solid tumors, glioma-bearing mice deficient in TNF developed larger tumors and had reduced survival compared with their wild-type controls. Histologic examinations revealed that glioma volume was negatively correlated with the number of macrophages and small cavities called microcysts. Overall, our results support the concept that macrophages alter brain tumor development through a TNF-dependent process that culminates in the formation of microcysts. This raises the question of whether anti-inflammatory drugs, such as those commonly administrated to patients with brain cancer, could interfere with antitumor mechanisms.

This article has been cited by other articles:

				J. Audoy-Remus, J.-F. Richard, D. Soulet, H. Zhou, P. Kubes, and L. Vallieres Rod-Shaped Monocytes Patrol the Brain Vasculature and Give Rise to Perivascular Macrophages under the Influence of Proinflammatory Cytokines and Angiopoietin-2 J. Neurosci., October 8, 2008; 28(41): 10187 - 10199. [Abstract] [Full Text] [PDF]

				H. Galarneau, J. Villeneuve, G. Gowing, J.-P. Julien, and L. Vallieres Increased Glioma Growth in Mice Depleted of Macrophages Cancer Res., September 15, 2007; 67(18): 8874 - 8881. [Abstract] [Full Text] [PDF]

				H. Zhong, B. Han, I. L. Tourkova, A. Lokshin, A. Rosenbloom, M. R. Shurin, and G. V. Shurin Low-Dose Paclitaxel Prior to Intratumoral Dendritic Cell Vaccine Modulates Intratumoral Cytokine Network and Lung Cancer Growth Clin. Cancer Res., September 15, 2007; 13(18): 5455 - 5462. [Abstract] [Full Text] [PDF]